FIELD: veterinary medicine. SUBSTANCE: preparation has animal and microbial origin having lysozyme activity in the following ingredient relation: egg protein lysozyme: microbial lysozyme ratio is equal to 1:1-2 in terms of activity. EFFECT: enhanced effectiveness in making lysis of both bacterial and fungous and protozoal cell walls. 12 tbl
Title | Year | Author | Number |
---|---|---|---|
CURATIVE-PROPHYLACTIC COSMETIC AGENT | 2000 |
|
RU2216313C2 |
METHOD OF TREATING PARASITIC DISEASES OF FISH | 2023 |
|
RU2819872C1 |
METHOD OF TREATING PARASITIC DISEASES OF FISH | 2023 |
|
RU2819870C1 |
MEANS FOR CONTROL OF FISH DISEASES | 2022 |
|
RU2808519C1 |
METHOD OF LYSOZYME-CONTAINING PRODUCT PREPARING | 1991 |
|
RU2021374C1 |
PHARMACEUTICAL COMPOSITION CONTAINING ENZYME RIBONUCLEASE AND GLYCYRRHIZIC ACID OR SALTS THEREOF: AMMONIUM OR DIPOTASSIUM OR TRISODIUM GLYCYRRHIZINATE | 2012 |
|
RU2504396C1 |
METHOD FOR BIOLOGICAL DISINFECTING OF STANDING POOLS FROM PATHOGENIC AND CONDITIONALLY PATHOGENIC MICROFLORA | 2001 |
|
RU2193531C2 |
TOOTH PASTE CONTAINING COMPLEX OF HYDROLASES | 2013 |
|
RU2527692C1 |
PREPARATION FOR CONTROL OF HARMFUL INSECT AND HELMINTH | 2000 |
|
RU2210362C2 |
PHARMACEUTICAL COMPOSITION CONTAINING LYSINE, PROLINE AND TRITERPENIC ACID DERIVATIVES FOR TREATING AND PREVENTING VIRAL INFECTIONS CAUSED BY RNA- AND DNA-CONTAINING VIRUSES, SUCH AS: INFLUENZA, HERPES, HERPES ZOSTER, HUMAN PAPILLOMA, ADENOVIRUSES, AS WELL AS BACTERIAL INFECTIONS CAUSED BY GRAM-POSITIVE AND GRAM-NEGATIVE MICROORGANISMS | 2013 |
|
RU2535052C1 |
Authors
Dates
2001-06-27—Published
2000-01-24—Filed